Treasure Sea Limited increases its stake in CMS (00867) by 500,000 shares, with an estimated price of approximately HK$7.55 per share.
On September 19th, Treasure Sea Limited increased its holdings of Kangzhe Pharmaceutical (00867) by 500,000 shares, with a price of 7.546 Hong Kong dollars per share, totaling 3.773 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on September 19th, Treasure Sea Limited increased its holdings of CMS (00867) by 500,000 shares at a price of 7.546 Hong Kong dollars per share, with a total amount of 3.773 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 1.166 billion shares, and the latest shareholding ratio is 47.80%.
This transaction involves another related party: Lin Gang.
Related Articles

EB SECURITIES: Shanghai Electric Group (02727) continues to make breakthroughs in emerging industries such as 25 years of nuclear fusion and Siasun Robot & Automation. We maintain a "buy" rating.

Guosheng Macro: Jobs in the United States show signs of improvement in March, but underlying worries remain.

Industrial: Market fluctuations intensify. How are various types of funds moving?
EB SECURITIES: Shanghai Electric Group (02727) continues to make breakthroughs in emerging industries such as 25 years of nuclear fusion and Siasun Robot & Automation. We maintain a "buy" rating.

Guosheng Macro: Jobs in the United States show signs of improvement in March, but underlying worries remain.

Industrial: Market fluctuations intensify. How are various types of funds moving?

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


